Sequome engineers biological sequences to develop therapeutics, building on our sequenceβfunction AI, Gene Genie, developed at MIT & the Broad and published on the cover of Nature.
Weβre fortunate to have had the opportunity to collaborate with ~half of Top-10 Pharma (watch our panel with J&J at the BIO International Convention on YouTube) & Google DeepMind (on AI co-scientist, also published on the cover of Nature), and we havenβt even publicly launched yet!
Our investors include a former CEO of Novartis, several Harvard Medical School professors, a MacArthur Genius Fellow faculty at Stanford, alongside leading Silicon Valley AI investors.
BIO panel with Johnson & Johnson on AI in Therapeutics
AI co-scientist paper with Google DeepMind, a Nature cover paper.
